EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 (Octobre 2007) Hors série n° 3 Med Sci (Paris), 23 (2007) 19-21 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Octobre 2007
Le cancer du sujet âgé : le dilemme du vieillissement
Page(s) 19 - 21
Section M/S revues
DOI https://doi.org/10.1051/medsci/2007233s19
Published online 15 October 2007
  1. Dimri GP, Campisi J. Molecular and cell biology of replicative senescence. Cold Spring Harb Symp Quant Biol 1994; 59 : 67–73. [Google Scholar]
  2. Dimri GP, Testori A, Acosta M, Campisi J. Replicative senescence, aging and growth-regulatory transcription factors. Biol Signals 1996; 5 : 154–62. [Google Scholar]
  3. Guarente L. Aging. What makes us tick ? Science 1997; 275 : 943–4. [Google Scholar]
  4. Guarente L. Chromatin and ageing in yeast and in mammals. Ciba Found Symp 1997; 211 : 104–11. [Google Scholar]
  5. McKeller RN, Fowler JL, Cunningham JJ, et al. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc Natl Acad Sci USA 2002; 99 : 3848–53. [Google Scholar]
  6. Groth A, Weber JD, Willumsen BM, et al. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J Biol Chem 2000; 275 : 27473–80. [Google Scholar]
  7. Weber GF, Ashkar S. Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers. Brain Res Bull 2000; 53 : 421–4. [Google Scholar]
  8. Weber GF, Ashkar S. Stress response genes : the genes that make cancer metastasize. J Mol Med 2000; 78 : 404–8. [Google Scholar]
  9. Burri N, Shaw P, Bouzourene H, et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001; 81 : 217–29. [Google Scholar]
  10. Kastan MB. Wild-type p53 : tumors can’t stand it. Cell 2007; 128 : 837–40. [Google Scholar]
  11. Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445 : 656–60. [Google Scholar]
  12. Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 1997; 15 : 203–11. [Google Scholar]
  13. Zindy F, Soares H, Herzog KH, et al. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ 1997; 8 : 1139–50. [Google Scholar]
  14. Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114 : 1299–307. [Google Scholar]
  15. Melk A, Schmidt BM, Takeuchi O, et al. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 2004; 65 : 510–20. [Google Scholar]
  16. Campisi J. Aging and cancer : the double-edged sword of replicative senescence. J Am Geriatr Soc 1997; 45 : 482–8. [Google Scholar]
  17. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21 : 525–30. [Google Scholar]
  18. Dietrich N, Bracken AP, Trinh E, et al. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J 2007; 26 : 1637–48. [Google Scholar]
  19. Gonzalez S, Klatt P, Delgado S, et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006; 440 : 702–6. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.